Cicic Dragan's most recent trade in SELLAS Life Sciences Group Inc was a trade of 169,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| SELLAS Life Sciences Group... | Dragan Cicic | SVP, Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 169,500 | 169,500 | - | - | Stock Option (Right to Buy) | |
| SELLAS Life Sciences Group... | Dragan Cicic | SVP, Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 113,000 | 228,328 (4%) | 2% | 0 | Common Stock | |
| SELLAS Life Sciences Group... | Dragan Cicic | SVP, Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 81,300 | 309,628 (6%) | 1% | 0 | Common Stock | |
| SELLAS Life Sciences Group... | Cicic Dragan | SVP, Chief Development Officer | Other type of transaction at price $ 1.13 per share. | 04 Dec 2024 | 8,256 | 115,328 (2%) | 0% | 1.1 | 9,329 | Common Stock |